Holen Sie sich die Stockscreener-App
320.42
4.15%
12.77
Vorhandelsmarkt:
322.66
2.24
+0.70%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$307.65
Offen:
$314.49
24-Stunden-Volumen:
8.68M
Relative Volume:
0.79
Marktkapitalisierung:
$400.95B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
60.48
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+10.41%
1M Leistung:
+2.91%
6M Leistung:
+60.75%
1J Leistung:
+204.96%
1-Tages-Spanne:
$312.03
$321.77
1-Wochen-Bereich:
$278.04
$321.77
52-Wochen-Spanne:
$104.46
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
320.42 | 384.97B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,764.85 | 658.69B | 41.20B | 12.41B | 11.15B | 32.12 |
AMAT
Applied Materials Inc
|
472.79 | 360.86B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
188.98 | 242.50B | 13.09B | 4.67B | 4.01B | 3.5373 |
TER
Teradyne Inc
|
372.06 | 55.82B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Applied Materials, AMD, Broadcom, Lam Research, and Marvell Technology Shares Skyrocket, What You Need To Know - Yahoo Finance
Waverly Advisors LLC Has $40.69 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
3,249 Shares in Lam Research Corporation $LRCX Acquired by CORDA Investment Management LLC. - MarketBeat
Lam Research Corp (LRCX) Shares Surge 4.2% -- What GF Score of 8 - GuruFocus
Lam Research (NASDAQ:LRCX) Shares Up 4.2%Time to Buy? - MarketBeat
Lam Research Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Lam Research (NASDAQ:LRCX): What’s Fueling the Buzz? - Kalkine Media
Lam Research Corp Stock (LRCX) Moved Up by 3.79% on Sep 8: What Investors Need To Know - TradingKey
Is Lam Research (LRCX) Stock Outpacing Its Computer and Technology Peers This Year? - Yahoo Finance
Why Lam Research (LRCX) is a Top Stock for the Long-Term - Zacks Investment Research
Lam Research (NASDAQ:LRCX) faces a fresh market test as trading resumes today - Kalkine Media
Ameritas Advisory Services LLC Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Nearly Triples in a Year: Is the Stock Still Worth Buying? - Yahoo Finance
Lam Research stock heads into the open after a 5.1 percent jump - AD HOC NEWS
HB Wealth Management LLC Sells 7,369 Shares of Lam Research Corporation $LRCX - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Has $18.28 Million Position in Lam Research Corporation $LRCX - MarketBeat
VCI Wealth Management LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
A Look at Lam Research Corp (LRCX) After 5.1% Gain -- GF Value $151.28 vs Price $307.65 - GuruFocus
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates - Quiver Quantitative
LAM RESEARCH CORP (NASDAQ: LRCX) Senior VP Varadarajan Seshasayee Disposes of 59,750 Shares at $291.32 Each - Kalkine Media
Lam Research and Tesla among market cap stock movers on Friday - Investing.com Canada
Lam Research Corp Stock (LRCX) Opened Up by 4.61% on Sep 4: What Investors Need To Know - TradingKey
Is the Options Market Predicting a Spike in Lam Research Stock? - Yahoo Finance
Lam Research (LRCX) Rises Higher Than Market: Key Facts - Yahoo Finance
Lam Research SVP Varadarajan Seshasayee sells $17.4m LRCX shares By Investing.com - Investing.com South Africa
Arbejdsmarkedets Tillaegspension's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research (NASDAQ: LRCX) officer unloads 59,750 shares under preset trading plan - Stock Titan
Nykredit A S Buys New Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ: LRCX) officer plans $17.4M Rule 144 stock sale - Stock Titan
Lam Research Corporation (LRCX) is Exploring Growth Opportunities in the Semiconductor Equipment Market - Yahoo Finance
Exploring Semiconductor Resurgence: Lam Research’s (LRCX) Role in Advanced Chip Manufacturing - Yahoo Finance
Is Lam Research Stock Outperforming the Nasdaq? - Yahoo Finance
Lam Research Corp (LRCX) Shares Fall 3.7% -- What GF Score of 85 Tells Investors - GuruFocus
Lam Research (NASDAQ:LRCX) Trading Down 3.7% After Insider Selling - MarketBeat
Lam Research Stock Under Pressure as UBS Cuts Target - Benzinga
Lam Research (NASDAQ:LRCX) Insider Sells $1,512,300.00 in Stock - MarketBeat
Pre-set sale by Lam Research (NASDAQ: LRCX) legal chief totals 5,000 shares - Stock Titan
Lam Research Corp Stock (LRCX) Opened Down by 3.30% on Sep 1: What Signal Does It Send? - TradingKey
Lam Research Launches Skill Development Program in India to Boost Advanced Manufacturing Talent - telugutimes.net
UBS Adjusts Price Target on Lam Research to $425 From $435, Maintains Buy Rating - Moomoo
Lam Research Corporation $LRCX Stake Increased by Proficio Capital Partners LLC - MarketBeat
Montanova Capital LLC Makes New $1.86 Million Investment in Lam Research Corporation $LRCX - MarketBeat
Taiwan Ministry OKs NT$9.8 Billion Investment by Lam Research - marketscreener.com
Lam Research: Buy The Summer Pullback (Rating Upgrade) - Seeking Alpha
Ministry approves Lam Research’s NT$9.8bn Taiwan investment - Taipei Times
Lam Research (NASDAQ: LRCX) officer proposes 5,000-share sale from 2026 vesting - Stock Titan
Wellington Management Group LLP Has $526.75 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
GTS Securities LLC Purchases 3,829 Shares of Lam Research Corporation $LRCX - MarketBeat
Flputnam Investment Management Co. Decreases Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Nissay Asset Management Corp Japan Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):